Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Technological innovations in detecting and studying protein–protein interactions are providing new ways of doing research in cell signalling. Diane Gershon investigates.
Biotech firms are vying to harness the potential of RNA interference. But will its impact be in finding new disease targets, or in RNA-based drugs? Julie Clayton investigates.
Synthesizing and selecting the lead compounds that will become the drugs of the future are the heart of drug discovery. Tim Chapman goes back to basics.
Protein arrays and protein assays in parallel are enabling researchers to look at protein interactions and activity on a large scale, as Lisa Melton finds out.